by healthadvances Posted on May 11, 2018 Scaling the Mountain: Adoption Strategy for Digital Health Read More
by healthadvances Posted on May 3, 2018 Patient Advocacy Groups as a Strategy for Orphan Drug Access in the UK Read More
by healthadvances Posted on April 10, 2018 PCSK9 Inhibitors’ Battle for Reimbursement: Germany’s Decision and Implications in Other Countries Read More
by healthadvances Posted on April 4, 2018April 5, 2018 Three Models for Population Health Technology Read More
by healthadvances Posted on April 3, 2018 Rare Disease Prevalence and Orphan Drug Pricing in Europe Read More
by healthadvances Posted on March 22, 2018April 10, 2018 Highlights of the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress Read More
by healthadvances Posted on March 14, 2018March 14, 2018 Seattle’s Journey to the Summit of Cancer Commercialization Read More
